0001104659-21-003042.txt : 20210111 0001104659-21-003042.hdr.sgml : 20210111 20210111171333 ACCESSION NUMBER: 0001104659-21-003042 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210111 DATE AS OF CHANGE: 20210111 EFFECTIVENESS DATE: 20210111 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ENB Therapeutics, Inc. CENTRAL INDEX KEY: 0001753420 IRS NUMBER: 473954174 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-385913 FILM NUMBER: 21521572 BUSINESS ADDRESS: STREET 1: C/O ALEXANDRIA CENTER FOR LIFE SCIENCES STREET 2: LAUNCHLABS 430 E 29TH ST. 14TH FLOOR CITY: NEW YORK STATE: NY ZIP: 100116 BUSINESS PHONE: 212 792-2317 MAIL ADDRESS: STREET 1: C/O ALEXANDRIA CENTER FOR LIFE SCIENCES STREET 2: LAUNCHLABS 430 E 29TH ST. 14TH FLOOR CITY: NEW YORK STATE: NY ZIP: 100116 D 1 primary_doc.xml X0708 D LIVE 0001753420 ENB Therapeutics, Inc. C/O LAUNCHLABS 430 E 29TH ST., 14TH FLOOR NEW YORK NY NEW YORK 100116 212 792-2317 DELAWARE None None Corporation true 2018 Sumayah Jamal c/o LaunchLabs 430 E. 29th St., 14th Floor NEW YORK NY NEW YORK 10016 Executive Officer Director Fumitaka Mori c/o LaunchLabs 430 E. 29th St., 14th Floor NEW YORK NY NEW YORK 10016 Director Barbara Schilberg c/o LaunchLabs 430 E. 29th St., 14th Floor NEW YORK NY NEW YORK 10016 Director Albert Sokol c/o LaunchLabs 430 E. 29th St., 14th Floor NEW YORK NY NEW YORK 10016 Executive Officer Biotechnology Decline to Disclose 06b false 2021-01-07 false true true false 0 2600000 1282500 1317500 false 3 0 0 0 None except for normal operational expenses. false ENB Therapeutics, Inc. /s/Albert Sokol Albert Sokol Secretary 2021-01-11